Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nicorandil ameliorates bleomycin-induced pulmonary fibrosis in rats through modulating eNOS, iNOS, TXNIP and HIF-1α levels
Mohammed O. Kseibati, George S.G. Shehatou, Maha H. Sharawy, et al.
Life Sciences (2020) Vol. 246, pp. 117423-117423
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis
Jana Adamčáková, Daniela Mokrá
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4162-4162
Open Access | Times Cited: 122
Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics
Joel A. Mintz, Anastasia Vedenko, Omar Rosete, et al.
Vaccines (2021) Vol. 9, Iss. 2, pp. 94-94
Open Access | Times Cited: 118
Comprehensive review of potential drugs with anti-pulmonary fibrosis properties
Jie Ma, Gang Li, Han Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116282-116282
Open Access | Times Cited: 18
HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications
Chu-Yang Zeng, Xifeng Wang, Fuzhou Hua
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathways
Yue Xiong, Xiaochuan Cui, Yanjun Zhou, et al.
International Immunopharmacology (2021) Vol. 98, pp. 107780-107780
Closed Access | Times Cited: 48
Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway
Rania Alaaeldin, Reham H. Mohyeldin, Amany Abdlrehim Bekhit, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4665-4665
Open Access | Times Cited: 18
Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia
Mohammed O. Kseibati, Maha H. Sharawy, Hatem A. Salem
International Immunopharmacology (2020) Vol. 89, pp. 107011-107011
Closed Access | Times Cited: 36
Discussion of the material basis for prevention and treatment of pulmonary fibrosis using naturally medicinal and edible homologous herbs based on the dynamic process of Nrf2, NF-κB and TGF-β in PF
Yan Li, Jia Zheng, Fei Liu, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117911-117911
Closed Access
Is Inducible Nitric Oxide Synthase (iNOS) Promising as a New Target Against Pulmonary Hypertension?
Piotr Ryszkiewicz, Eberhard Schlicker, Barbara Malinowska
Antioxidants (2025) Vol. 14, Iss. 4, pp. 377-377
Open Access
Extracellular vesicles from hypoxia-preconditioned mesenchymal stem cells alleviates myocardial injury by targeting thioredoxin-interacting protein-mediated hypoxia-inducible factor-1α pathway
Chengyu Mao, Tiantian Zhang, Dongjiu Li, et al.
World Journal of Stem Cells (2022) Vol. 14, Iss. 2, pp. 183-199
Open Access | Times Cited: 18
Trigonelline mitigates bleomycin-induced pulmonary inflammation and fibrosis: Insight into NLRP3 inflammasome and SPHK1/S1P/Hippo signaling modulation
Menna S. Zeyada, Salma M. Eraky, Mamdouh M. El‐Shishtawy
Life Sciences (2023) Vol. 336, pp. 122272-122272
Closed Access | Times Cited: 10
Capsaicin ameliorate pulmonary fibrosis via antioxidant Nrf-2/ PPAR- γ pathway activation and inflammatory TGF-β1/ NF-κB/COX II pathway inhibition
Wesam H. Abdulaal, Hani Z. Asfour, Nawal Helmi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Modulation in NF-κB-p65/NLRP3, TXNIP-mediated signaling using an ethanolic fruit extract of Withania coagulans mitigates silica-induced pulmonary fibrosis in rats
Kaveri R. Washimkar, Amol Chhatrapati Bisen, Shobhit Verma, et al.
Fitoterapia (2025) Vol. 183, pp. 106578-106578
Closed Access
Detection of Type I and III collagen in porcine acellular matrix using HPLC–MS
Yang Zhang, Yi Chen, Bo Zhao, et al.
Regenerative Biomaterials (2020) Vol. 7, Iss. 6, pp. 577-582
Open Access | Times Cited: 24
Protective effect of dimethyl itaconate against fibroblast–myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP
Yongyue Han, Xuan Gu, Chong‐Yang Yang, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 11, pp. 7734-7744
Closed Access | Times Cited: 23
Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis
Dalia H. El‐Kashef, Mahmoud E. Youssef, Mohamed Hussein Arbab Nasr, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113487-113487
Open Access | Times Cited: 16
Vinpocetine's immunomodulating, anti-oxidant, anti-inflammatory, ant-ifibrotic, and PDE inhibiting potencies ameliorate bleomycin-induced pulmonary fibrosis.
Mohamed Balaha, Abdullah K. Alahmari, Samah Kandeel, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2023) Vol. 26, Iss. 1, pp. 13-22
Closed Access | Times Cited: 9
Identification of New Targets and the Virtual Screening of Lignans against Alzheimer’s Disease
Mayara dos Santos Maia, Gabriela Cristina Soares Rodrigues, Natália Ferreira de Sousa, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 22
METFORMIN MITIGATES SEPSIS-ASSOCIATED PULMONARY FIBROSIS BY PROMOTING AMPK ACTIVATION AND INHIBITING HIF-1α–INDUCED AEROBIC GLYCOLYSIS
Han Zhong, Ri Tang, Jinhua Feng, et al.
Shock (2023) Vol. 61, Iss. 2, pp. 283-293
Closed Access | Times Cited: 6
SRC‐3 Knockout Attenuates Myocardial Injury Induced by Chronic Intermittent Hypoxia in Mice
Wanyu Wang, Hongbo Gu, Weihua Li, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 14
Hypothesis: The potential therapeutic role of nicorandil in COVID‐19
Hend Ashour, Mohamed H. Elsayed, Soha Elmorsy, et al.
Clinical and Experimental Pharmacology and Physiology (2020) Vol. 47, Iss. 11, pp. 1791-1797
Open Access | Times Cited: 13
Nicorandil mitigates folic acid‐induced nephrotoxicity in mice: Role of iNOS and eNOS
Dalia M. Ezzat, Asmaa M. Soliman, Dalia H. El‐Kashef
Journal of Biochemical and Molecular Toxicology (2021) Vol. 35, Iss. 4
Closed Access | Times Cited: 12
Betanin protects against bleomycin-induced pulmonary fibrosis by regulating the NLRP3/IL-1β/TGF-β1 pathway-mediated epithelial-to-mesenchymal transition
Nesma A. Abd Elrazik, Sahar A. Helmy
Food & Function (2023) Vol. 15, Iss. 1, pp. 284-294
Closed Access | Times Cited: 4
Therapeutic potential of nicorandil beyond anti-anginal drug: A review on current and future perspectives
Dhirendra Singh, Randhir Singh, Abidemi J. Akindele
Heliyon (2024) Vol. 10, Iss. 7, pp. e28922-e28922
Open Access | Times Cited: 1
Nicorandil mitigates amiodarone‐induced pulmonary toxicity and fibrosis in association with the inhibition of lung TGF‐β1/PI3K/Akt1‐p/mTOR axis in rats
Inas Harb, Hend Ashour, Laila A. Rashed, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 50, Iss. 1, pp. 96-106
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top